LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission

被引:64
|
作者
Hioe, CE
Chien, PC
Lu, CF
Springer, TA
Wang, XH
Bandres, J
Tuen, M
机构
[1] Vet Adm Med Ctr, Res Serv, New York, NY 10010 USA
[2] NYU, Sch Med, New York, NY 10010 USA
[3] Ctr Blood Res, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1128/JVI.75.2.1077-1082.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
While CD4 and the chemokine receptors are the principal receptors for human immunodeficiency virus (HN), other cellular proteins, such as LFA-1, are also involved in HIV infection. LFA-1 end its ligands, ICAM-1, ICAM-2, and ICAM-3, can be expressed on the cells infected by HIV, as well as on the HIV virions themselves. To examine the role of LFA-1 expressed on target cells in HIV infection, Jurkat-derived J beta2.7 T-cell lines that express either wild-type LFA-1, a constitutively active mutant LFA-1, or no LFA-1 were used, The presence of wild-type LFA-1 enhanced the initial processes of HIV infection, as well as the subsequent replication and transmission from cell to cell. In contrast, the constitutively active LFA-1 mutant failed to promote virus replication and spread, even though this mutant could help HIV enter cells and establish the initial infection. This study clearly demonstrates the contribution of LFA-T in the different stages of HIV infection. Moreover, not only is LFA-1 expression important for initial HN-cell interaction, subsequent replication, and transmission, but its activity must also be properly regulated.
引用
收藏
页码:1077 / 1082
页数:6
相关论文
共 50 条
  • [1] Role of LFA-1 in the transmission and pathogenesis of human immunodeficiency virus type 1 (HIV-1)
    Walker, Tiffany Nicole
    Hildreth, James E. K.
    [J]. FASEB JOURNAL, 2009, 23
  • [2] LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1
    Tardif, MR
    Tremblay, MJ
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (21) : 13714 - 13724
  • [3] LFA-1 Antagonists as Agents Limiting Human Immunodeficiency Virus Type 1 Infection and Transmission and Potentiating the Effect of the Fusion Inhibitor T-20
    Tardif, Melanie R.
    Gilbert, Caroline
    Thibault, Sandra
    Fortin, Jean-Francois
    Tremblay, Michel J.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4656 - 4666
  • [4] T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1
    Fortin, JF
    Cantin, R
    Tremblay, MJ
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 2105 - 2112
  • [5] ANTIBODY TO ADHESION MOLECULE LFA-1 ENHANCES PLASMA NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    GOMEZ, MB
    HILDRETH, JEK
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (08) : 4628 - 4632
  • [6] Virus and target cell evolution in human immunodeficiency virus type 1 infection
    Donald E. Mosier
    [J]. Immunologic Research, 2000, 21 : 253 - 258
  • [7] Virus and target cell evolution in human immunodeficiency virus type 1 infection
    Mosier, DE
    [J]. IMMUNOLOGIC RESEARCH, 2000, 21 (2-3) : 253 - 258
  • [8] HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION IN CD4+ LYMPHOCYTES-T GENETICALLY DEFICIENT IN LFA-1 - LFA-1 IS REQUIRED FOR HIV-MEDIATED CELL-FUSION BUT NOT FOR VIRAL TRANSMISSION
    PANTALEO, G
    BUTINI, L
    GRAZIOSI, C
    POLI, G
    SCHNITTMAN, SM
    GREENHOUSE, JJ
    GALLIN, JI
    FAUCI, AS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (02): : 511 - 514
  • [9] Follicular dendritic cells and infection by human immunodeficiency virus type 1 - A crucial target cell and virus reservoir
    Schuurman, HJ
    Joling, P
    vanWichen, DF
    Rademakers, LHPM
    Broekhuizen, R
    deWeger, RA
    vandenTweel, JG
    Goudsmit, J
    [J]. ANTIGEN DEPOSITORY OF THE IMMUNE SYSTEM: FOLLICULAR DENDRITIC CELLS, 1995, 201 : 161 - 188
  • [10] LFA-1 on Leukemic Cells as a Target for Therapy or Drug Delivery
    Phongpradist, Rungsinee
    Chittasupho, Chuda
    Okonogi, Siriporn
    Siahaan, Teruna
    Anuchapreeda, Songyot
    Ampasavate, Chadarat
    Berkland, Cory
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (21) : 2321 - 2330